化合物Desmorpholinyl Navitoclax-NH-Me T39910

Product Introduction
Bioactivity


英文名: Desmorpholinyl Navitoclax-NH-Me

描述: Desmorpholinyl Navitoclax-NH-Me (Desmorpholinyl ABT-263-NH-Me) is a Bcl-xL inhibitor, which can be employed alongside a CRBN ligand to synthesize XZ739, a PROTAC BCL-XL degrader [1] [2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 100 mg/mL (108.87 mM)


关键字: inhibit | Target Protein-binding Moiety | Bcl-2 Family | Desmorpholinyl NavitoclaxNHMe | Inhibitor | Desmorpholinyl Navitoclax NH Me | Ligands for Target Protein for PROTAC

相关产品: (E)-Ferulic acid | HA14-1 | Panaxynol | Sappanchalcone | 3',6-Disinapoylsucrose | Serratenediol | BI-3802 | Jolkinolide B | Se-Methylselenocysteine | BCL6-IN-3

相关库: Anti-Cancer Compound Library | Mitochondria-Targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | PPI Inhibitor Library | Cuproptosis Compound Library | Bioactive Compound Library

化合物Desmorpholinyl Navitoclax-NH-Me T39910信息由TargetMol中国为您提供，如您想了解更多关于化合物Desmorpholinyl Navitoclax-NH-Me T39910报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途